BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21983893)

  • 21. Endoscopic ultrasound-guided fine-needle aspiration can lead to nonresectability of pancreatic cancer due to severe biopsy-induced inflammation.
    Dahl S; Mortensen MB
    Endoscopy; 2008 Sep; 40 Suppl 2():E96. PubMed ID: 19085713
    [No Abstract]   [Full Text] [Related]  

  • 22. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.
    Miller PW; Sharma S; Stolina M; Butterfield LH; Luo J; Lin Y; Dohadwala M; Batra RK; Wu L; Economou JS; Dubinett SM
    Hum Gene Ther; 2000 Jan; 11(1):53-65. PubMed ID: 10646639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
    Obi Y
    Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery.
    West E; Morgan R; Scott K; Merrick A; Lubenko A; Pawson D; Selby P; Hatfield P; Prestwich R; Fraser S; Eves D; Anthoney A; Twelves C; Beirne D; Patel P; O'Donnell D; Watt S; Waller M; Dietz A; Robinson P; Melcher A
    J Immunother; 2009 Jan; 32(1):66-78. PubMed ID: 19307995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
    Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
    Peng LS; Zhuang Y; Shi Y; Zhao YL; Wang TT; Chen N; Cheng P; Liu T; Liu XF; Zhang JY; Zuo QF; Mao XH; Guo G; Lu DS; Yu PW; Zou QM
    Cancer Immunol Immunother; 2012 Nov; 61(11):2183-92. PubMed ID: 22729557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer.
    Hanna N; Ohana P; Konikoff FM; Leichtmann G; Hubert A; Appelbaum L; Kopelman Y; Czerniak A; Hochberg A
    Cancer Gene Ther; 2012 Jun; 19(6):374-81. PubMed ID: 22498722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intra-lymph nodal injection of OK-432 for treatment of lymph node metastasis].
    Okano S; Sawai K; Fujioka T; Yamaguchi M; Sakakura C; Kanemitsu K; Seiki K; Hagiwara A; Takahashi T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1598-600. PubMed ID: 1530315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.
    Aguilar LK; Shirley LA; Chung VM; Marsh CL; Walker J; Coyle W; Marx H; Bekaii-Saab T; Lesinski GB; Swanson B; Sanchez D; Manzanera AG; Aguilar-Cordova E; Bloomston M
    Cancer Immunol Immunother; 2015 Jun; 64(6):727-36. PubMed ID: 25795132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
    Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
    Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
    Hosokawa T
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of immune cell infiltration within gallbladder cancer.
    Nakakubo Y; Miyamoto M; Cho Y; Hida Y; Oshikiri T; Suzuoki M; Hiraoka K; Itoh T; Kondo S; Katoh H
    Br J Cancer; 2003 Nov; 89(9):1736-42. PubMed ID: 14583778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T; Ziske C; Märten A; Endres S; Tiemann K; Schmitz V; Gorschlüter M; Schneider C; Sauerbruch T; Schmidt-Wolf IG
    Cancer Res; 2003 Dec; 63(24):8962-7. PubMed ID: 14695214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours.
    Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S
    Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Infiltration of dendritic cells into cervical lymph nodes in laryngeal carcinoma].
    Zhang J; Xu J; Jia S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):472-4. PubMed ID: 12768765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytologic changes following intratumoral high dose injection of OK-432 in advanced pancreatic cancers and gall bladder cancers with ultrasound guidance].
    Okano Y; Takenaka A; Kasugai H; Morii T; Kishigami Y; Okuda S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1892-3. PubMed ID: 6882009
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
    Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.